News
Jay Bhattacharya’s tenure as NIH director has seen health disparities research swept up in the Trump administration’s attack ...
An advocacy group is suing the Trump administration for failing to disclose details of a settlement with Gilead over patent ...
President Trump escalated his demands that pharma firms lower U.S. prices in line with what other countries pay, sending ...
The introduction of GLP-1s for weight loss has been a dysfunctional mess, thanks to pharmaceutical companies, insurance plans ...
Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...
In early June, a MAGA influencer named Chuck Callesto launched a social media assault on Sen. Bill Cassidy, a Louisiana ...
Science evolves as both controlled clinical research and real-world evidence show us how to use health care technologies to ...
The reshaping of the CDC's vaccine advisory panel has continued, with the apparent barring of reps of medical associations ...
Senators from both parties endorsed a $400 million increase to the budget of the National Institutes of Health on Thursday ...
The Trump administration has proposed a pilot initiative to address controversy over the 340B drug discount program.
The order applies to the entirety of new and, possibly, ongoing research grant dollars that go to universities and academic ...
Vinay Prasad is my former student and friend. His departure from FDA is a loss for American medicine
It is hard to imagine someone more equipped and more dedicated to vetting treatments than Vinay Prasad,” writes his former ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results